Best high-risk merchant account for SARMs operators in 2026
- SARMs are declined by every major US payfac (Stripe, Square, PayPal, Shopify Payments) — no workaround.
- Viable: Authorize.net via a nutra/research-chemical ISO, NMI gateway, or offshore acquirer. Expect 4-5.5% effective.
- Multi-brand SARMs operators often consolidate onto a parent MID with orchestrated sub-brand descriptors to cut underwriting overhead.
On this page
SARMs underwriting is harder than peptide underwriting and softer than explicit research-chemical underwriting. You will spend most of your search filtering out ISOs who say "yes" on the phone and then decline you when they see the SKU list. Here is the honest mapping of who actually writes SARMs in 2026, what they charge, and how to stay live once you are approved.
1. Who will NEVER approve SARMs
- Stripe — SARMs sits squarely in Restricted Businesses (unapproved pharma / research chemicals). Any SARMs operator currently on Stripe is in the review window, not the sustainable state.
- Square — Same outcome after SKU review, usually 60-120 days in.
- PayPal / Braintree — AUP excludes SARMs as both drug and drug paraphernalia.
- Shopify Payments — Stripe underneath in the US.
- Amazon Pay — declines on category.
2. ISOs that regularly approve SARMs
EasyPayDirect (Authorize.net)
One of the few ISOs that names SARMs in its vertical pages. Effective rate 4.0-4.9%, 10-15% reserve for 180 days. Setup fee $0-$500. Two-year contract typical with $295 ETF.
PayKings (Authorize.net / NMI)
SARMs book, tighter SKU scrutiny than EasyPayDirect. Effective 4.2-5.2%, 15% reserve 180 days. Slightly more willing on edge-case research chemicals.
Durango Merchant Services
Writes SARMs case-by-case. Rates similar to above, reserves 15-20% on newer accounts.
High Risk Pay
Broader high-risk book including SARMs. Marketing is aggressive; read the contract — monthly minimums and PCI fees are higher than average.
Soar Payments
Newer but has done SARMs. Slightly softer underwriting on first-year operators, sometimes at higher rate.
Corepay
Nutra specialist, occasional SARMs approval when the SKU list is tight and marketing is restrained.
3. Offshore options (for $300k+/mo)
- Emerchantpay (EU) — SARMs under specific country-licensing conditions, 5-6% effective, 15-20% reserve 360 days.
- Paynetics (EU) — specialty high-risk book, willing on SARMs for operators with EU-structured entities.
- Global Payments Canada — occasionally, with a legitimate Canadian entity and Canadian processor-of-record.
Cross-border fees are 1-2% per transaction on US-card-to-EU-acquirer flows. Chargeback resolution is 2-3x slower. Worth it only if you cannot land domestic approval or you are above the domestic volume ceiling.
4. Parent-account orchestration (for multi-brand SARMs operators)
If you run 3+ SARMs / nutra-adjacent brands under one parent entity, per-brand ISO accounts mean N separate underwriting cycles, N reserve pools, N chargeback queues. A consolidated parent MID with orchestrated sub-brand descriptors runs every brand under one acquirer relationship while preserving sub-brand descriptor on the statement. That is what multiflow orchestrates.
5. What to evaluate on every SARMs contract
Rate structure
4.0-4.9% effective is the domestic SARMs floor in 2026. Anything quoted under 3.8% on a new account is either a teaser rate (read month-6) or the ISO is about to close you. Interchange-plus is preferable to flat-rate.
Reserve
10-20% rolling reserve for 180 days is typical. Push back on anything over 20% or durations over 180 days without a documented release schedule.
Chargeback ratio threshold
Ask literally: "What ratio pauses my account? What ratio ends the relationship?" Typical SARMs thresholds: 0.75% pause, 1.0% review. Anything vague = walk.
Volume cap
New SARMs accounts routinely get $100-300k/mo caps that lift after 90-180 days of clean processing. If your forecast exceeds the cap, confirm the lift schedule in writing.
Contract and ETF
2-3 year contracts with $250-500 ETFs are standard. Negotiate month-to-month after year 1 if possible. Some ISOs will agree; most will not.
6. Chargeback prevention (more important on SARMs than anywhere else)
SARMs chargeback ratios run higher than nutra average because refund policy disputes, product-effect disputes, and confused customers all end up at the card issuer. Required tooling:
- Ethoca + Verifi chargeback alerts (not included with most ISO deals — wire separately).
- Clear refund policy above the fold on product pages.
- Descriptor matching between site brand name and statement descriptor (reduces "I didn't recognize the charge" disputes significantly).
- Delivery confirmation on every order — signature required above $200.
See our full SARMs chargeback prevention playbook.
7. The MATCH question
If you have ever been closed by Stripe or Square for SARMs, confirm MATCH status before applying. Our MATCH playbook covers the removal process (same for SARMs).
8. Our honest recommendation
Single-brand SARMs operator under $80k/mo: apply to EasyPayDirect and PayKings in parallel. Pick on rate + chargeback threshold + ETF. Plan on 7-10 business days to approval.
Multi-brand SARMs operator (3+ brands or expanding into nutra/peptide adjacencies): the parent-account orchestration math often wins. Apply in 12 questions — we will tell you honestly whether the portfolio fits or whether a single-brand ISO is the better call for where you are today.